Patent details

91889 Product Name: 8-(3-Aminopiperidin-1-yl)-7-but-2-inyl-3-methyl-1-(4-methylchinazolin-2-ylmethyl)-3,7-dihydropurin-2,6-dion, les énantiomères et leurs sels, en particulier la Linagliptine**Linagliptine=((R)-8-(3-Aminopiperidin-1-yl)-7-but-2-inyl-3-methyl-1-(4-methylchinazolin-2-ylmethyl)-3,7-dihydropurin-2,6-dion) (IUPAC)

Basic Information

Publication number:
91889
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP037923596
Legal Status:
Active
Application number:
91889
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
11/04/2024
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
04/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/11/707/001-011
Marketing Authorization Type:
Marketing Authorization Date:
30/08/2011
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
21/10/2011
First Marketing Authorization date:
30/08/2011
Grant date:
21/12/2011
Activation date:
18/08/2023
Publication date:
21/12/2011
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
30/08/2026
SPC Extension Expiration:
28/02/2027
Rejection date:
Withdrawal date:

Owner

From:
21/10/2011
 
 

Name:
Boehringer Ingelheim Pharma GmbH & Co. KG
Address:
-, 55216 Ingelheim am Rhein, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
21/10/2011
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
LOTZ Ralf, Richard, Hermann
Address:
Germany (DE)

2

Name:
LANGKOPF Elke
Address:
Germany (DE)

3

Name:
ECKHARDT Matthias
Address:
Germany (DE)

4

Name:
HIMMELSBACH Frank
Address:
Germany (DE)

5

Name:
MAIER Roland
Address:
Germany (DE)

6

Name:
MARK Michael
Address:
Germany (DE)

7

Name:
TADAYYON Mohammad
Address:
United Kingdom (GB)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2024/06
Publication date:
06/05/2024
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/08/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
430 Euro
Payer:
DENNEMEYER & CO